Navigation Links
NPL unveils new equipment to make cancer treatment safer
Date:11/14/2008

NPL unveils new equipment to make cancer treatment safer

A new piece of medical technology unveiled at the National Physical Laboratory (NPL) today will help improve the success rates of radiotherapy cancer treatments. The new clinical electron linear accelerator (linac) will help ensure patients are treated with accurate doses of radiation.

Radiotherapy treats cancer, by using ionising radiation such as high-energy X-rays or electron beams, to destroy cancer cells. Every hospital needs to ensure that its radiotherapy equipment is stable and accurate because delivering correct radiation doses is critical. If the dose is too low, the cancer may continue to grow. If it is too high, healthy tissue could be damaged.

NPL's new clinical linac's ability to provide highly stable beams and accurate doses will enable calibrations with smaller uncertainties. This will allow hospitals to deliver more accurate, and more effective, radiation doses to cancer patients.

The new facility helps the UK respond to a recent report from the National Radiotherapy Advisory Group (NRAG) which states that the UK has a huge gap between the number of people treated with radiotherapy and optimal treatment levels. The number of people treated is increasing by 100,000 per year but this is still far short of the number of treatments required. The aging population means that more people than ever will require radiotherapy treatment in the future and a 91% increase in activity is needed by 2016 to hit targets.

One of the benefits of the new linac is that it will greatly speed up the calibration process.

"The linac will vastly reduce the time it takes to calibrate equipment. Its new technology allows it to calibrate the full range of beam qualities currently in therapeutic use in the UK in a very short period of time," says Acting Managing Director of NPL Dr Martyn Sene.

Professor Mike Richards, the National Clinical Director for Cancer at the Department of Health stressed the importance of the facility today.

"'The new linac at the National Physical Laboratory is an important step forward in the fight against cancer. Hospitals can now be confident that their radiotherapy instruments will be calibrated more accurately and efficiently than ever before."

NPL's new clinical linac is a 1.5 million government-funded investment. It will allow NPL scientists to calibrate hospital equipment against the UK's primary standard of absorbed dose using beams of ionising radiation identical to those used in hospitals. It has been manufactured and installed by Elekta, a UK-based supplier of radiotherapy linacs.


'/>"/>

Contact: Jim Sutton
jim@proofcommunication.com
084-568-01867
National Physical Laboratory
Source:Eurekalert

Related biology news :

1. EC unveils new EU maritime policy
2. Tumor genome analysis unveils new insights into lung cancer
3. Sirtris unveils promising, novel SIRT1 activators for treating diseases of aging
4. Research unveils new hope for deadly childhood disease
5. LTER unveils a new decadal science plan
6. Pixelplus Unveils Its PM1002 as A Practical Biometric Solution for Iris, Facial and Fingerprint Recognition
7. Washington University unveils draft sequence of corn genome
8. Synchrotron light unveils oil in ancient Buddhist paintings from Bamiyan
9. CrimeCog Technologies Unveils Enhanced JMS Module of E*JUSTICE SYSTEMS(TM)
10. FBI unveils science of anthrax investigation
11. Promptu Unveils High Accuracy Voice-to-Text Dictation for Mobile Phones at CTIA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2016)... 2016 http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ... "Emotion Detection and Recognition Market by ... Software Tools (Facial Expression, Voice Recognition and ... - Global forecast to 2020" report ... http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has announced the addition of ...
(Date:2/2/2016)...   Parabon NanoLabs (Parabon) announced today ... Office and the Defense Forensics and Biometrics Agency ... company,s Snapshot Kinship Inference software for ... defense-related DNA forensics.  Although Snapshot is best known ... ancestry from DNA evidence), it also has the ...
(Date:1/28/2016)... Synaptics (NASDAQ: SYNA ), a leading developer of human interface ... 31, 2015. --> --> ... percent compared to the comparable quarter last year to $470.5 million. ... million, or $0.93 per diluted share. --> ... of fiscal 2016 grew 9 percent over the prior year period ...
Breaking Biology News(10 mins):
(Date:2/6/2016)... VA (PRWEB) , ... February 06, 2016 , ... The ... session, cost-free, for middle and high school teachers on Wednesday February 10, 2016. ... held at the Smithsonian-Mason School of Conservation, located at 1500 Remount Road in Front ...
(Date:2/5/2016)... 2016 Amarantus BioScience Holdings, Inc. ... on developing products for Regenerative Medicine, Neurology and Orphan ... Designation (RPDD) from the US Food and Drug Administration ... was previously granted orphan drug designation (ODD) by the ... BioScience Holdings, Inc. (OTCQB: AMBS), a ...
(Date:2/4/2016)... ... February 04, 2016 , ... Shimadzu Scientific Instruments ... host live demos and poster sessions, and present on the analysis of mycotoxins ... place March 6 to 10 at the Georgia World Congress Center in Atlanta, ...
(Date:2/4/2016)... , February 4, 2016 ... a biotechnology acceleration company is pleased to provide the following ... --> Over the last 3 months we have ... securities purchase agreements exceeding $1,000,000. As a result, we have ... Mannin Research Inc. license agreement and expect that development to ...
Breaking Biology Technology: